A randomized, single blinded, placebo-controlled, multi-centre, phase II study of lapatinib in patients with locally advanced squamous cell carcinoma of the head and neck.

Trial Profile

A randomized, single blinded, placebo-controlled, multi-centre, phase II study of lapatinib in patients with locally advanced squamous cell carcinoma of the head and neck.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2011

At a glance

  • Drugs Antineoplastics; Lapatinib
  • Indications Head and neck cancer; Squamous cell cancer
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 27 May 2011 New source identified and integrated (European Clinical Trials Database).
    • 27 May 2011 Actual initiation date changed from Mar 2006 to 30 Nov 2005 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top